Abstract Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative
etiology of 'Corona Virus Disease-2019'(COVID-19); formerly referred as 'novel-Coronavirus …

Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …

During the 2018–2020 Ebola virus disease (EVD) outbreak in North Kivu province in the
Democratic Republic of Congo, EVD was diagnosed in a patient who had received the …

The global spread of the novel coronavirus (SARS-CoV-2) and increasing rate of mortality
among different countries has raised the global concern regarding this disease. This illness …

Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …

Convalescent plasma has emerged as a promising therapeutic agent for patients with
coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is …

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

Since SARS-CoV-2 infection is rapidly spreading all around the world, affecting many
people and exhausting health care resources, therapeutic options must be quickly …

Introduction. The consistent emergence/reemergence of filoviruses into a world that
previously lacked an approved pharmaceutical intervention parallels an experience …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for
coronavirus disease 2019 (COVID-19), has rapidly spread, resulting in considerable …